1. Gilead says remdesivir cut risk of COVID patient death in clinical trial — BioNTech-Pfizer COVID vaccine expected to be ready for approval by year end — LEO Pharma eyeing 2021 launch for Dupixent rival — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

88305 Song

Discussion in 'GI Path' started by Anonymous, Oct 20, 2014 at 1:20 PM.

  1. Anonymous

    Anonymous Guest

    whats going on in path these days? Labs still profitable?
     
  2. Anonymous

    Anonymous Guest

    this lab in imploding. key people leaving and no new business. oh well. time to run. was told big lay offs this coming year. paths and reps
     
  3. Anonymous

    Anonymous Guest

    Is that blowhard chuck still there?? Is the company in trouble or is the company profitable?
     
  4. Anonymous

    Anonymous Guest

    Is chuck m still at this company??
     
  5. Anonymous

    Anonymous Guest

    he is gone, along with other senior managers gone. reps looking hard